Currency / Forex
Market News
ADRs End Mixed; LightInTheBox Opens Blockchain Lab
Top / Flop
Friday, 19 January
IBM returns to growth, but shares drop after recent rally
1d ago - (Reuters) - International Business Machines Corp's revenue rose for the first time in 23 quarters and beat analysts' estimates as the company's shift into its focus areas such as cloud computing and security services gains traction.
Cold weather chills U.S. homebuilding; jobless claims at 45-year low
1d ago - WASHINGTON (Reuters) - U.S. homebuilding fell more than expected in December, recording its biggest drop in just over a year, likely as unseasonably cold weather at the end of the month disrupted the construction of single-family housing units.
Thyssenkrupp CEO says will sharpen strategy - Handelsblatt
1d ago - FRANKFURT (Reuters) - German industrial and technology group Thyssenkrupp (>> thyssenKrupp) will refine its corporate strategy soon, its chief executive told a German newspaper in the wake of growing investor criticism over the company's structure and performance.
European shares edge higher as cyclicals back in favour
1d ago - LONDON (Reuters) - European shares notched up modest gains on Thursday, led higher by a fresh rise for so-called cyclical stocks while company updates and ratings changes from brokers spurred moves among individual names.
Peugeot CEO outlines ambitious plan to re-enter U.S., go electric
1d ago - DETROIT (Reuters) - Peugeot SA (>> Peugeot) Chief Executive Carlos Tavares said on Wednesday the French automaker is using the know-how of former Opel engineers acquired from General Motors Co (>> General Motors Corporation) to develop vehicles to re-enter the U.S. market, and said Peugeot will offer electrification as an option on all its vehicles by 2025.
Deutsche Telekom to split T-Systems unit under new leadership
1d ago - BERLIN (Reuters) - Deutsche Telekom is planning to split its IT services and consulting business T-Systems into two separate units in a bid to halt a slide in earnings, a spokesman for Deutsche Telekom said, confirming a newspaper report.
U.S. court invalidates Johnson & Johnson cancer drug patent, hitting UK's BTG
1d ago - NEW YORK (Reuters) - A U.S. administrative court invalidated a Johnson & Johnson (>> Johnson & Johnson) patent on its blockbuster prostate cancer drug Zytiga, bringing rivals closer to selling generic versions and hitting shares in its British partner BTG Plc (>> BTG).
For GE, Huge Disassembly Required -- WSJ
1d ago - By Thomas Gryta This article is being republished as part of our daily reproduction of articles that also appeared in the U.S. print...
More news